Before there were any cases of novel coronavirus confirmed in South Korea, one of the country's biotech firms had begun preparing to make testing kits to identify the disease. On January 16, Chun Jong-yoon, the chief executive and founder of molecular biotech company Seegene, told his team it was time to start focusing on coronavirus. That was before the virus sweeping China had been named Covid-19 and four days ahead of South Korea confirming its first case.